Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer

C Rybak, MJ Hall

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Colorectal cancer (CRC) risk assessment involves the evaluation of an individual's personal and family history for characteristics of an inherited susceptibility to develop CRC. Lynch syndrome (LS), or hereditary nonpolyposis colorectal cancer, is the most common cause of hereditary CRC, underlying 2% to 3% of patients with newly diagnosed (incident) CRC. Risk assessment for LS is complex, and the interpretation of the many available tests can be challenging even for the genetics specialist. A move toward universal (reflex) LS screening for mismatch repair in all patients with incident CRC supports the importance of improving the awareness and understanding of LS testing, teaching rational testing approaches, and honing interpretive skills among cancer care providers. This article reviews important clinical features of LS genetic evaluation using 3 pedigree-based case examples from the Fox Chase Cancer Center Gastrointestinal Risk Assessment Clinic.

Original languageAmerican English
Pages (from-to)1311-1320
Number of pages10
JournalJournal of the National Comprehensive Cancer Network
Volume9
Issue number11
DOIs
StatePublished - Nov 1 2011

Keywords

  • Adaptor Proteins, Signal Transducing/genetics
  • Adenosine Triphosphatases/genetics
  • Aged
  • Carcinoma/complications
  • Colorectal Neoplasms, Hereditary Nonpolyposis/complications
  • DNA Mutational Analysis
  • DNA Repair Enzymes/genetics
  • DNA-Binding Proteins/genetics
  • Data Interpretation, Statistical
  • Female
  • Genetic Testing/methods
  • Humans
  • Male
  • Microsatellite Instability
  • Middle Aged
  • Mismatch Repair Endonuclease PMS2
  • MutL Protein Homolog 1
  • Nuclear Proteins/genetics
  • Pedigree

Fingerprint

Dive into the research topics of 'Interpretation of Genetic Testing for Lynch Syndrome in Patients With Putative Familial Colorectal Cancer'. Together they form a unique fingerprint.

Cite this